Operating Lease, Right-of-Use Asset of Generation Bio Co. from 31 Dec 2020 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Generation Bio Co. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2020 to 30 Sep 2025.
  • Generation Bio Co. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $17,429,000, a 18% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Generation Bio Co. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $17,429,000 -$3,791,000 -18% 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $18,415,000 -$3,692,000 -17% 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 $19,375,000 -$3,595,000 -16% 31 Mar 2025 10-Q 07 May 2025 2025 Q1
Q4 2024 $20,310,000 -$49,542,000 -71% 31 Dec 2024 10-Q 05 Nov 2025 2025 Q3
Q3 2024 $21,220,000 -$33,194,000 -61% 30 Sep 2024 10-Q 06 Nov 2024 2024 Q3
Q2 2024 $22,107,000 -$33,727,000 -60% 30 Jun 2024 10-Q 07 Aug 2024 2024 Q2
Q1 2024 $22,970,000 -$34,975,000 -60% 31 Mar 2024 10-Q 13 May 2024 2024 Q1
Q4 2023 $69,852,000 +$10,644,000 +18% 31 Dec 2023 10-K 13 Mar 2025 2024 FY
Q3 2023 $54,414,000 -$6,712,000 -11% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 $55,834,000 -$7,124,000 -11% 30 Jun 2023 10-Q 02 Aug 2023 2023 Q2
Q1 2023 $57,945,000 -$4,937,000 -7.9% 31 Mar 2023 10-Q 10 May 2023 2023 Q1
Q4 2022 $59,208,000 -$5,935,000 -9.1% 31 Dec 2022 10-K 06 Mar 2024 2023 FY
Q3 2022 $61,126,000 +$29,874,000 +96% 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 $62,958,000 +$30,970,000 +97% 30 Jun 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 $62,882,000 +$30,176,000 +92% 31 Mar 2022 10-Q 05 May 2022 2022 Q1
Q4 2021 $65,143,000 +$15,443,000 +31% 31 Dec 2021 10-K 23 Feb 2023 2022 FY
Q3 2021 $31,252,000 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 $31,988,000 30 Jun 2021 10-Q 11 Aug 2021 2021 Q2
Q1 2021 $32,706,000 31 Mar 2021 10-Q 12 May 2021 2021 Q1
Q4 2020 $49,700,000 31 Dec 2020 10-K 18 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.